$Cerebras Systems(CBRS)$ Cerebras just got coverage from two analysts. UBS initiated with a Buy rating and a $300 price target. Morgan Stanley initiated with an Overweight rating and a $250 price target. Both are bullish on the stock at its current level around $201.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
